PAMU
ENTA icon

Pictet Asset Management (UK)’s Enanta Pharmaceuticals ENTA Stock Holding History

Pictet Asset Management (UK)’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30,806
Closed -$1.52M – 1786
2021
Q1 		$1.52M Buy
+30,806
New +$1.54M ﹤0.01% 1004
2015
Q2 		– Sell
-116,700
Closed -$4M – 889
2015
Q1 		$4M Buy
+116,700
New +$4.54M 0.02% 629

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Pictet Asset Management (UK)'s ENTA Position: Q2 2021 in Review

Pictet Asset Management (UK) sold out of Enanta Pharmaceuticals (ENTA) in Q2 2021, closing a stake of 30,806 shares — an estimated $1.52M sold.

Pictet Asset Management (UK) first reported a position in ENTA in Q1 2015 and held it in 2 quarters. The position peaked at $4M in Q1 2015. 151 funds tracked by Wall St. Rank hold ENTA as of Q2 2021.

  • Pictet Asset Management (UK) reported no remaining Enanta Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 30,806 Enanta Pharmaceuticals shares in Q2 2021, an estimated $1.52M.
  • Pictet Asset Management (UK) first reported a position in Enanta Pharmaceuticals in Q1 2015 and held it in 2 quarters.
  • Pictet Asset Management (UK)'s Enanta Pharmaceuticals position peaked at $4M in Q1 2015.
  • 151 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.